BRKR - Rasio Kapitalisasi Pasar marang Nilai Buku Bruker BioSpin

Bruker (BRKR) - logo korporat

Bruker Corporation (BRKR) builds its competitive advantage in biotechnology and proteomics through instrument complexity that is difficult to replicate, although the business remains vulnerable to US trade restrictions and logistical disruptions. This chart of the company's share price with the 3.65 indicator reflects the price action of the high-precision systems manufacturer. Its success relies on the symbiosis of mass spectrometry and specialized software, which has become the standard for modern laboratories.

Bruker BioSpin (BRKR) - Kapitalisasi Pasar marang Nilai Buku saka 04.07.2022 nganti 01.11.2026

Rincian metrik lan analitis perusahaan Bruker Corp (BRKR)

- nilai pasar lan prakiraan target analis:
Bagan rega Bruker Corporation|BRKR - Konsensus nilai wajar
- statistik kapitalisasi pasar:
Kapitalisasi pasar Bruker Corp.|BRKR - Nilai Bisnis
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Bruker|BRKR - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku bruker.com|BRKR - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Bruker Corporation|BRKR - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Bruker Corp.|BRKR - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Bruker Corp.|BRKR - Utang jangka dawa|Utang jangka cendhak perusahaan Bruker|Indikator likuiditas cepet bruker.com
- indikator bathi lan kelipatan valuasi:
BRKR - Bathi sawise mbayar pajeg
Ringkesan analisis perusahaan:Bruker Corporation
Barang unggulan Bruker Corp.

The high-tech ecosystem of Bruker Corporation (BRKR), which integrates precision mass spectrometers and specialized software, forms a capital-intensive foundation for fundamental research. By analyzing the price-to-book chart, an investor determines the gap between actual net assets and market expectations, identifying the risk of overvaluation or hidden impairment when market sentiment ceases to be supported by the objective cost of capital.

Analisis perusahaan pesaing

Abbott Laboratories (ABT) - Rasio Nilai Pasar marang Nilai Buku|thermofisher.com - Nilai Pasar marang Nilai Buku|GEHC (GE HealthCare Technologies) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku MTD (Mettler-Toledo)|Rasio Kapitalisasi Pasar marang Nilai Buku WAT|Kapitalisasi Pasar marang Nilai Buku Bio-Techne Inc.|Rasio Kapitalisasi Pasar marang Nilai Buku AZTA (Azenta, Inc.)|Rasio Kapitalisasi Pasar marang Nilai Buku vareximaging.com VREX|Semler Scientific - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Ekuitas Butterfly Network Inc (BFLY)|Mesa Labs Corp (MLAB) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku QSI|Rasio Nilai Pasar marang Nilai Buku Nano-X Imaging Ltd.|Koefisien Nilai Pasar marang Nilai Buku quanterix.com QTRX|Rasio Nilai Pasar marang Nilai Buku 908 Devices (MASS)|Kapitalisasi Pasar marang Nilai Buku capsovision.com|MaxCyte, Inc - Rasio Kapitalisasi marang Aset Bersih|Multiplikator Kapitalisasi Pasar marang Nilai Buku RPID (Rapid Micro Biosystems Inc.)|Seer, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku hyperfine.io HYPR|FONR: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Daxor|Rasio Kapitalisasi marang Aset Bersih MDAI|VIVS: Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Aclarion (ACON)|Rasio Kapitalisasi marang Aset Bersih akoyabio.com AKYA|Rasio Kapitalisasi Pasar marang Nilai Buku THMO (ThermoGenesis Holdings)|Talis Biomedical Corp. (TLIS) - Koefisien Nilai Pasar marang Nilai Buku|T2 Biosystems, Inc - Rasio Kapitalisasi Pasar marang Nilai Buku